grant

Randomised placebo-controlled trial of carvedilol in dialysis patients: effects on cardiac and other relevant parameters [ 2010 - 2013 ]

Also known as: The Beta-blocker to LOwer CArdiovascular Dialysis Events (BLOCADE) Trial

Funded by National Health and Medical Research Council
Managed by The University of Melbourne
Managed by University of Melbourne
Provided by   National Health and Medical Research Council

Research Grant

[Cite as http://purl.org/au-research/grants/nhmrc/628902]

Researchers: Dr Matthew Roberts (Principal investigator)

Funding Amount $AUD 179,708.51

Funding Scheme Early Career Fellowships

Notes Health Professional Research ECF

Click to explore relationships graph
Help

Related Publications

  • Associated with ANGIOTENSIN-CONVERTING ENZYME 2 ACTIVITY IN PATIENTS WITH CHRONIC KIDNEY DISEASE
    handle : 11343/41373
  • Associated with Temporal Trajectory of B-Type Natriuretic Peptide in Patients with CKD Stages 3 and 4, Dialysis, and Kidney Transplant
    handle : 11343/57521

Related Organisations

Related People

Subjects
Clinical Sciences | Medical and Health Sciences | Nephrology and Urology | cardiovascular disease | drug action | morbidity | randomised controlled trial | renal failure |
Identifiers
Viewed: [[ro.stat.viewed]]
Saved to MyRDA Save to MyRDA